{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"akt2-related-familial-partial-lipodystrophy","columns":[{"gene":"","key":"population-7dd98915049f96c1df71","label":"AKT2-related familial partial lipodystrophy","mondoId":"MONDO:0019192","onsetQualifier":null,"originColumnKey":"MONDO:0019192/ORPHA:79085","originalViews":[{"key":"MONDO:0019192/ORPHA:79085","label":"AKT2-related familial partial lipodystrophy","scopeLabel":"ORPHA:79085","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["06b0ac44f81dc86afdf2a57e1c7123824aa4c0c8454102f054072a28be66bc84","074c20418f6e13b34906707b6e090a8198415019b512730fc7ac5771df9bece8","08b2193aa5d7208bc4e12b78e5d04cc0162c9f0a33400cde8fbb2e69cce82da7","2774a89d3af7131f9270ac5c37e15b7a235b931113af6d7c486440b7dea62974","38cafb53dc27e432c7f8f4befe8b6269dc1615e6e8621b5a66ba7f1546bb51a3","39cd7a00c47467845bb393ba1facd3689de5d5298dc56a0db4be06b709888452","5f7c3a9fccd721737fe20fceb0a9c95482d575d6e1b45d119d4fd66f2bb5f321","69c176115777c937539758d73cd0a9a1791068c282b61755a7319df3bdad63b5","6f4706fabb888985aa4e7bc56ec2fadb943b29d17e1c1f3e6f8daf7a6094a05f","825f8e5de8c640e1c7577fa122ea036c17c349120542caa5a2ba893145fd26b4","a083c4ba10040a36990da45e51f9e24b886727dbe3940a23ce399e2bed9684bf","f2b6b8183589f51db5743af312b5a34e89f5c84c9f643132d4d252b00671c958"],"recordQualifiers":{},"scopeLabel":"ORPHA:79085","sourceIds":["ORPHA:79085"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7dd98915049f96c1df71"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000956","HP:0030685","HP:0003292","HP:0001397","HP:0002240","HP:0002155","HP:0008993"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":12}},"features":[{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0030685","label":"Decreased adiponectin level","primary":true},{"hpoId":"HP:0003292","label":"Decreased serum leptin","primary":true},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":true},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":true},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":true},{"hpoId":"HP:0008993","label":"Increased intraabdominal fat","primary":true},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0009125","label":"Lipodystrophy","primary":false},{"hpoId":"HP:0000876","label":"Oligomenorrhea","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false}],"ledeHtml":"A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy and severe insulin resistance in the liver and peripheral tissues, hyperinsulinemia, and diabetes mellitus. Acanthosis nigricans and hypertension have been reported in association.","mondoId":"MONDO:0019192","node":{"canonicalSlug":"akt2-related-familial-partial-lipodystrophy","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"AKT2-related familial partial lipodystrophy","originalSourceId":"ORPHA:79085","paragraphs":["A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy and severe insulin resistance in the liver and peripheral tissues, hyperinsulinemia, and diabetes mellitus. Acanthosis nigricans and hypertension have been reported in association."],"rawAttribution":"ORPHA:79085","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:40Z","upstream":"ORPHA:79085","url":"https://rarediseases.info.nih.gov/diseases/12599"},"ownColumnKeys":["population-7dd98915049f96c1df71"],"publication":"published","relationships":[{"kind":"parent","label":"familial partial lipodystrophy","mondoId":"MONDO:0020088","slug":"familial-partial-lipodystrophy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"06b0ac44f81dc86afdf2a57e1c7123824aa4c0c8454102f054072a28be66bc84","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003292","is_excluded":false,"label":"Decreased serum leptin","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"074c20418f6e13b34906707b6e090a8198415019b512730fc7ac5771df9bece8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"08b2193aa5d7208bc4e12b78e5d04cc0162c9f0a33400cde8fbb2e69cce82da7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008993","is_excluded":false,"label":"Increased intraabdominal fat","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2774a89d3af7131f9270ac5c37e15b7a235b931113af6d7c486440b7dea62974","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"38cafb53dc27e432c7f8f4befe8b6269dc1615e6e8621b5a66ba7f1546bb51a3","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"39cd7a00c47467845bb393ba1facd3689de5d5298dc56a0db4be06b709888452","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5f7c3a9fccd721737fe20fceb0a9c95482d575d6e1b45d119d4fd66f2bb5f321","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"69c176115777c937539758d73cd0a9a1791068c282b61755a7319df3bdad63b5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f4706fabb888985aa4e7bc56ec2fadb943b29d17e1c1f3e6f8daf7a6094a05f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"825f8e5de8c640e1c7577fa122ea036c17c349120542caa5a2ba893145fd26b4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030685","is_excluded":false,"label":"Decreased adiponectin level","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a083c4ba10040a36990da45e51f9e24b886727dbe3940a23ce399e2bed9684bf","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f2b6b8183589f51db5743af312b5a34e89f5c84c9f643132d4d252b00671c958","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79085","disease_name":"AKT2-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"ORPHA:79085","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12599\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:79085</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy and severe insulin resistance in the liver and peripheral tissues, hyperinsulinemia, and diabetes mellitus. Acanthosis nigricans and hypertension have been reported in association.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12599\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"akt2-related-familial-partial-lipodystrophy","sourceDocuments":[{"name":"GARD: AKT2-related familial partial lipodystrophy","reviewed":null,"source_release":"2026-10-25T03:41:40Z","url":"https://rarediseases.info.nih.gov/diseases/12599"}],"sourceNote":"","synonyms":["AKT2-related FPLD","familial partial lipodystrophy due to AKT2 mutations"],"takeawayHtml":"","title":"AKT2-related familial partial lipodystrophy"},"schemaVersion":1}
